°C
Air:
GOLD—
SILVER—
USD—
EUR—
GBP—
Increase in Respiratory Infections Due to Rhinovirus and Human Metapneumovirus in China; Experts Caution Against Blind Use of Antiviral Drugs
Health

Increase in Respiratory Infections Due to Rhinovirus and Human Metapneumovirus in China; Experts Caution Against Blind Use of Antiviral Drugs

0.0 views
Text Size:

A prominent respiratory expert from a Shanghai hospital, in an interview with Reuters, emphasized that blindly using antiviral drugs could lead to several health complications, including drug resistance.

China is currently facing a surge in respiratory infections caused by pathogens such as rhinovirus and human metapneumovirus (HMPV), particularly in northern provinces. This rise in infections comes during the winter season, a time when respiratory illnesses are generally more prevalent. As reported by Reuters, HMPV infections are notably increasing among individuals under the age of 14, raising concerns among health authorities and the public.

HMPV is a respiratory virus that belongs to the Paramyxoviridae family and was first identified in 2001. It is one of the most common causes of respiratory infections, particularly among vulnerable populations like young children, the elderly, and those with compromised immune systems. The symptoms of HMPV are often similar to those of the common cold, including cough, congestion, fever, difficulty breathing, and fatigue. However, in individuals with weakened immunity, HMPV can lead to more severe conditions such as bronchitis and pneumonia.

Despite its prevalence, there is currently no specific vaccine or antiviral treatment available for HMPV. Health experts have strongly cautioned against the indiscriminate use of antiviral drugs to treat this virus. A prominent respiratory expert from a Shanghai hospital, in an interview with Reuters, emphasized that blindly using antiviral drugs could lead to several health complications, including drug resistance. It is crucial to avoid over-medication, especially in the case of a virus like HMPV, which is self-limiting and typically resolves with supportive care.

Given the moderate contagious nature of HMPV, it spreads primarily through respiratory droplets when an infected person coughs, sneezes, or talks. The virus can also be transmitted through direct contact with contaminated surfaces or objects. Close interactions, particularly in crowded or enclosed spaces, increase the likelihood of transmission. Individuals are most contagious during the early stages of the illness, particularly when symptoms such as coughing and sneezing are prominent. Children, the elderly, and those with compromised immune systems are at a higher risk of contracting the virus.

To prevent the spread of HMPV, experts recommend several preventive measures:

  • Covering the mouth and nose when coughing or sneezing
  • Washing hands frequently with soap and water for at least 20 seconds
  • Avoiding the sharing of cups and eating utensils with others
  • Refraining from kissing or close contact with others while ill
  • Staying at home when sick to avoid spreading the virus to others

The National Centre for Disease Control (NCDC) in India is closely monitoring respiratory infections and seasonal influenza cases in the country. According to official sources, the NCDC is in contact with international health agencies to stay informed about the latest developments related to HMPV and other respiratory viruses. The outbreak of HMPV in China highlights the importance of heightened surveillance and early detection mechanisms to prevent the spread of respiratory infections, particularly in high-density populations.

Dr. Arjun Dang, CEO of Dr. Dang's Lab, pointed out that HMPV is a relatively underrecognized pathogen, often overshadowed by other respiratory viruses like the flu and RSV. However, during flu seasons, cases of HMPV have been routinely reported, particularly among vulnerable populations such as young children, older adults, and those with weakened immune systems. This recent outbreak in China serves as a reminder of the evolving challenges posed by respiratory viruses and the need for increased awareness and preparedness to combat their spread.

While there is no cause for panic, the rise in HMPV cases globally emphasizes the importance of taking preventive measures, especially during the colder months when respiratory infections are more common. As health authorities continue to monitor the situation, it is essential for individuals to remain vigilant an

Despite its prevalence, there is currently no specific vaccine or antiviral treatment available for HMPV.